MAP kinase kinase 1 (MAP2K1; MEK1); MAP kinase kinase 2 (MAP2K2; MEK2) BriefCommunication Pages: 1061 - 1061
CC chemokine receptor 4 (CCR4; CD194); epidermal growth factor receptor 2 (EGFR2; HER2; ErbB2; neu); E7 transforming protein (Human papillomavirus-16; HpV16gp1); Silver homolog (SILV; PMEL17; GP100) BriefCommunication Pages: 1062 - 1062
Panton-Valentine leukocidin (LukS-PV; pv); Panton-Valentine leukocidin chain F precursor (LukF-PV) BriefCommunication Pages: 1070 - 1070
Characterization of genetic determinants of disease risk and response to medical therapy using publicly available sequencing data BriefCommunication Pages: 1075 - 1075
Fibronectin scaffolds for targeted and potent growth factor delivery in vivo BriefCommunication Pages: 1076 - 1076
Polysilsesquioxane nanoparticles for targeted platinum-based chemotherapy release BriefCommunication Pages: 1077 - 1077
Penetration through the blood brain barrier using adenosine receptor agonists BriefCommunication Pages: 1078 - 1078
Markers to predict nonresponders to interferon-α and ribavirin treatment for HCV BriefCommunication Pages: 1079 - 1079